Filing Details
- Accession Number:
- 0001483813-13-000098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-16 18:46:24
- Reporting Period:
- 2013-09-13
- Filing Date:
- 2013-09-16
- Accepted Time:
- 2013-09-16 18:46:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247653 | Stuart John Patton | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-13 | 100,000 | $0.39 | 230,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-13 | 37,500 | $9.10 | 192,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-16 | 37,500 | $9.16 | 155,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to Purchase Common Stock (NSO) | Disposition | 2013-09-13 | 100,000 | $0.39 | 100,000 | $0.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-12-09 | 2013-12-09 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.07 to $9.17. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.075 to $9.24. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a secruity holder of the Issuer full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
